Skip to main content
TipRanks
Go Ultimate75% OFF

Intellia Therapeutics (0JBU) Income Statement

7 Followers

Intellia Therapeutics Income Statement

Last quarter (Q3 2026), Intellia Therapeutics's total revenue was $7.16M, a decrease of 48.03% from the same quarter last year. In Q3, Intellia Therapeutics's net income was $-127.48M. See Intellia Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 67.67M$ 57.88M$ 36.27M$ 52.12M$ 33.05M
$ 51.75M$ 47.59M$ 27.30M$ 44.55M$ 26.16M
$ 492.74M$ 581.86M$ 542.59M$ 502.71M$ 294.01M
Depreciation and Amortization$ 15.92M$ 10.29M$ 8.98M$ 7.57M$ 6.89M
$ -396.77M$ -508.74M$ -472.22M$ -466.61M$ -261.00M
$ -440.99M$ -534.26M$ -515.29M$ -458.16M$ -267.85M
$ 28.30M$ 15.24M$ 34.10M$ -16.02M$ -42.00K
$ -412.69M$ -519.02M$ -481.19M$ -474.19M$ -267.89M
$ -412.69M$ -519.02M$ -481.19M$ -474.19M$ -267.89M
Per Share Metrics
Basic EPS$ -3.81$ -5.25$ -5.42$ -6.16$ -3.78
Diluted EPS$ -3.81$ -5.25$ -5.42$ -6.16$ -3.78
Weighted Average Shares Outstanding108.38M98.85M88.77M76.97M70.89M
Weighted Average Shares Outstanding (Diluted)108.38M98.85M88.77M76.97M70.89M

Currency in USD

Intellia Therapeutics Earnings and Revenue History

-600M-300M0300M-1500 %-1000 %-500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin